Patents Assigned to CLARK PHARMACEUTICALS, LLC
  • Composition and method of treating actinic purpura
    Patent number: 10842731
    Abstract: The present invention is a composition and method of treatment for actinic purpura, skin disorders, and skin conditions in general through topical systematic and periodic application of a formulation that generally may include ingredients to improve circulation such as but not limited to arnica oil CLR and phytotonine; ingredients to thicken the skin such as but not limited to retistar, glycolic acid, vitamin K1, and phyto-age; and ingredients to repair the skin's barrier, such as but not limited to timecode, SKINMIMICS, ABS pomegranate sterols, and pentatavitin.
    Type: Grant
    Filed: January 17, 2017
    Date of Patent: November 24, 2020
    Assignee: Clark Pharmaceuticals LLC
    Inventor: Stephen W. Clark
  • Composition and method of treating skin conditions
    Patent number: 10130573
    Abstract: The present invention is a composition and method of treatment for skin disorders, conditions, and severe skin dryness in general through topical systematic and periodic application of a formulation that generally may include salicylic acid, glycolic acid, urea, dimethyl isosorbide, ethoxydiglycol, barrier repair agents, anti-irritants, humectants, and also has an acidic pH formulation.
    Type: Grant
    Filed: June 19, 2017
    Date of Patent: November 20, 2018
    Assignee: Clark Pharmaceuticals LLC
    Inventors: Stephen W. Clark, Natalie Barger
  • Composition and method of treating actinic purpura
    Patent number: 9579355
    Abstract: The present invention is a composition and method of treatment for actinic purpura, skin disorders, and skin conditions in general through topical systematic and periodic application of a formulation that generally may include ingredients to improve circulation such as but not limited to arnica oil CLR and phytotonine; ingredients to thicken the skin such as but not limited to retistar, glycolic acid, vitamin K1, and phyto-age; and ingredients to repair the skin's barrier, such as but not limited to timecode, SKINMIMICS, ABS pomegranate sterols, and pentatavitin.
    Type: Grant
    Filed: September 27, 2013
    Date of Patent: February 28, 2017
    Assignee: Clark Pharmaceuticals LLC
    Inventors: Stephen W. Clark, Natalie Barger
  • Composition and method of treating skin conditions
    Patent number: 9399009
    Abstract: The present invention is a composition and method of treatment for skin disorders, conditions, and severe skin dryness in general through topical systematic and periodic application of a formulation that generally may include salicylic acid, glycolic acid, urea, dimethyl isosorbide, ethoxydiglycol, barrier repair agents, anti-irritants, humectants, and also has an acidic pH formulation.
    Type: Grant
    Filed: February 26, 2015
    Date of Patent: July 26, 2016
    Assignee: CLARK PHARMACEUTICALS, LLC
    Inventors: Stephen W. Clark, Natalie Barger
  • N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as AA agonists
    Patent number: 9067963
    Abstract: The present invention provides N-alkyl 2-(disubstituted)alkynyladenosine-5?-uronamides and derivatives thereof and pharmaceutical compositions containing the same that are selective agonists of A2A adenosine receptors (ARs). These compounds and compositions are useful as pharmaceutical agents.
    Type: Grant
    Filed: July 31, 2013
    Date of Patent: June 30, 2015
    Assignee: Lewis and Clark Pharmaceuticals, LLC
    Inventors: Robert D Thompson, Anthony Beauglehole, Guoquan Wang